PATENT CLAIM ANALYSIS

Application Number: 16043504
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["424", "135100"]

Abstract:
The disclosure is directed to novel predictive methods and personalized therapies for treating asthma. Specifically, this disclosure relates to methods of treating a patient having asthma by selectively administering an IL-13 antagonist, on the basis of that patient being genetically predisposed to have a favorable response to treatment with the IL-13 antagonist. Also disclosed herein are transmittable forms of information, diagnostic methods, and kits useful in predicting the likelihood that a patient having asthma will respond to treatment with an IL-13 antagonist.

Claim (Index 5):
The method according to  claim 2 , wherein the step of assaying comprises assaying the biological sample for a nucleic acid product of the at least one AIR marker, or a polypeptide product of the at least one AIR marker.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 95.0
- Lexical Diversity: 1.58929
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15302348', '15969952', '14978183', '14457566', '15041514']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6748394445479627
- 35 USC 102 Novelty (BERT): 0.5994146639241604
- Combined Prediction Score: 0.6672969664855826
- Mean Citation Score: 300.79763
- Max Citation Score: 503.8454
- Similarity Product: 457.0458313827037

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test